U.S. Markets closed

Biocon Limited (BIOCON.BO)

Bombay Stock Exchange - Bombay Stock Exchange Real Time Price. Currency in INR
Add to watchlist
328.00+1.00 (+0.31%)
At close: 3:49PM IST
Full screen
Previous Close327.00
Open328.80
Bid0.00 x 0
Ask0.00 x 0
Day's Range326.20 - 332.40
52 Week Range267.83 - 424.15
Volume235,380
Avg. Volume467,972
Market Cap64.33B
BetaN/A
PE Ratio (TTM)7.32
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Capital Cubeyesterday

    Biocon Ltd. – Value Analysis (BSE INDIA:532523) : August 21, 2017

    Categories: Asia Pacific Value Yahoo FinanceClick here to see latest analysis Capitalcube gives Biocon Ltd. a score of 66. Our analysis is based on comparing Biocon Ltd. with the following peers – Jubilant Life Sciences Limited, Pfizer India Ltd., Piramal Enterprises Ltd., Torrent Pharmaceuticals Ltd, NATCO Pharma Limited, Bilcare Limited, Cipla Limited, Sanofi India Limited, Glenmark Pharmaceuticals Limited and Strides ... Read more (Read more...)

  • Biocon Ltd. breached its 50 day moving average in a Bearish Manner : 532523-IN : August 10, 2017
    Capital Cube13 days ago

    Biocon Ltd. breached its 50 day moving average in a Bearish Manner : 532523-IN : August 10, 2017

    Categories: Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Biocon Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Biocon Ltd. :532523-IN: Earnings Analysis: 2017 By the Numbers : July 6, 2017
    Capital Cube2 months ago

    Biocon Ltd. :532523-IN: Earnings Analysis: 2017 By the Numbers : July 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Biocon Ltd. reports financial results for the year ended March 31, 2017. Highlights Gross margins widened from 24.99% to 26.91% compared to the same period last year, operating (EBITDA) margins now 22.27% from 19.42%. Change in operating cash flow of 80.23% compared to same period last year is about the same ... Read more (Read more...)